中国医学创新
中國醫學創新
중국의학창신
MEDICAL INNOVATION OF CHINA
2013年
27期
37-38
,共2页
米非司酮%胎盘植入%产科
米非司酮%胎盤植入%產科
미비사동%태반식입%산과
Mifepristone%Placenta implantation%Obstetrical department
目的：探讨米非司酮在治疗胎盘植入中的作用。方法：选取本院2011年1月-2013年1月收治的60例有胎盘植入情况的孕妇为研究对象，随机分为观察组与对照组，每组30例。所有患者均进行基础治疗与护理，观察组服用米非司酮，对照组服用缩宫素，比较两组患者产后出血量、分娩情况和清宫率之间的差异。结果：观察组产后出血量低于对照组，胎盘组织排出时间、B超恢复时间和血β-hCG恢复时间均少于对照组，清宫率低于对照组，比较差异均有统计学意义（P<0.05）。结论：米非司酮可以在治疗胎盘植入的过程中发挥积极作用，能够降低产后出血，加速胎盘排出，减轻患者医疗负担。
目的：探討米非司酮在治療胎盤植入中的作用。方法：選取本院2011年1月-2013年1月收治的60例有胎盤植入情況的孕婦為研究對象，隨機分為觀察組與對照組，每組30例。所有患者均進行基礎治療與護理，觀察組服用米非司酮，對照組服用縮宮素，比較兩組患者產後齣血量、分娩情況和清宮率之間的差異。結果：觀察組產後齣血量低于對照組，胎盤組織排齣時間、B超恢複時間和血β-hCG恢複時間均少于對照組，清宮率低于對照組，比較差異均有統計學意義（P<0.05）。結論：米非司酮可以在治療胎盤植入的過程中髮揮積極作用，能夠降低產後齣血，加速胎盤排齣，減輕患者醫療負擔。
목적：탐토미비사동재치료태반식입중적작용。방법：선취본원2011년1월-2013년1월수치적60례유태반식입정황적잉부위연구대상，수궤분위관찰조여대조조，매조30례。소유환자균진행기출치료여호리，관찰조복용미비사동，대조조복용축궁소，비교량조환자산후출혈량、분면정황화청궁솔지간적차이。결과：관찰조산후출혈량저우대조조，태반조직배출시간、B초회복시간화혈β-hCG회복시간균소우대조조，청궁솔저우대조조，비교차이균유통계학의의（P<0.05）。결론：미비사동가이재치료태반식입적과정중발휘적겁작용，능구강저산후출혈，가속태반배출，감경환자의료부담。
Objective:To analyze the effect of mifepristone in the treatment of placenta implantation.Method:60 pregnant weman with placenta implantation were divided into the observation group and the control group,30 cases in each group.The observation group was given mifepristone on the basis of conventional therapy,and the control group was given oxytocin.The difference of postpartum blood loss,delivery conditions and the rate of scrape the uterus was compared.Result:The amount of postpartum hemorrhage in the observation group was lower than that in the control group.Bultrasound placenta discharge time,recovery time and recovery time of bloodβ-hCG were less than that of the control group,the rate of scrape the uterus was lower than that of the control group,there were statistically significant differences(P<0.05).Conclusion:Mifepristone can play an active role in the process of placenta accreta treatment,with the less postpartum blood,more positive in the delivery conditions and lower health care burden.
